Efficacy of Sunitinib in Advanced Medullary Thyroid Carcinoma: Intermediate Results of Phase II THYSU

Por Ravaud, Alain, de la Fouchardière, Christelle, Asselineau, Julien, Delord, Jean-Pierre, Do Cao, Christine, Niccoli, Patricia, Rodien, Patrice, Klein, Marc, Catargi, Bogdan
Publicado em 2010

Impact of KRAS, BRAF and PI3KCA mutations in rectal carcinomas treated with neoadjuvant radiochemotherapy and surgery

Por Derbel, Olfa, Wang, Qing, Desseigne, Françoise, Rivoire, Michel, Meeus, Pierre, Peyrat, Patrice, Stella, Mattia, Martel-Lafay, Isabelle, Lemaistre, Anne-Isabelle, de La Fouchardière, Christelle
Publicado em 2013

Results of combined treatment of anaplastic thyroid carcinoma (ATC)

Por Derbel, Olfa, Limem, Sami, Ségura-Ferlay, Céline, Lifante, Jean-Christophe, Carrie, Christian, Peix, Jean-Louis, Borson-Chazot, Françoise, Bournaud, Claire, Droz, Jean-Pierre, de la Fouchardière, Christelle
Publicado em 2011

Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter stu...

Por Adenis, Antoine, de la Fouchardiere, Christelle, Paule, Bernard, Burtin, Pascal, Tougeron, David, Wallet, Jennifer, Dourthe, Louis-Marie, Etienne, Pierre-Luc, Mineur, Laurent, Clisant, Stéphanie, Phelip, Jean-Marc, Kramar, Andrew, Andre, Thierry
Publicado no BMC Cancer (2016)

Erratum to: Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a mul...

Por Adenis, Antoine, de la Fouchardiere, Christelle, Paule, Bernard, Burtin, Pascal, Tougeron, David, Wallet, Jennifer, Dourthe, Louis-Marie, Etienne, Pierre-Luc, Mineur, Laurent, Clisant, Stéphanie, Phelip, Jean-Marc, Kramar, Andrew, Andre, Thierry
Publicado no BMC Cancer (2016)

Lysyl oxidase family activity promotes resistance of pancreatic ductal adenocarcinoma to chemotherapy by limiting the intratumoral anticancer drug distribution

Por Le Calvé, Benjamin, Griveau, Audrey, Vindrieux, David, Maréchal, Raphaël, Wiel, Clotilde, Svrcek, Magali, Gout, Johann, Azzi, Lamia, Payen, Léa, Cros, Jérôme, de la Fouchardière, Christelle, Dubus, Pierre, Guitton, Jérôme, Bartholin, Laurent, Bachet, Jean-Baptiste, Bernard, David
Publicado no Oncotarget (2016)

Sorafenib in locally advanced or metastatic, radioactive iodine-refractory, differentiated thyroid cancer: a randomized, double-blind, phase 3 trial

Por Brose, Marcia S, Nutting, Christopher M, Jarzab, Barbara, Elisei, Rossella, Siena, Salvatore, Bastholt, Lars, de la Fouchardiere, Christelle, Pacini, Furio, Paschke, Ralf, KeeShong, Young, Sherman, Steven I, Smit, Johannes WA, Chung, John, Kappeler, Christian, Pena, Carol, Molnár, István, Schlumberger, Martin J
Publicado no Lancet (2014)

Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort

Por Portal, Alix, Pernot, Simon, Tougeron, David, Arbaud, Claire, Bidault, Anne Thirot, de la Fouchardière, Christelle, Hammel, Pascal, Lecomte, Thierry, Dréanic, Johann, Coriat, Romain, Bachet, Jean-Baptiste, Dubreuil, Olivier, Marthey, Lysiane, Dahan, Laetitia, Tchoundjeu, Belinda, Locher, Christophe, Lepère, Céline, Bonnetain, Franck, Taieb, Julien
Publicado no Br J Cancer (2015)

The sum of gains and losses of genes encoding the protein tyrosine kinase targets predicts response to multi-kinase inhibitor treatment: Characterization, validation, and prognosti...

Por Jiang, Xiaojun, Pissaloux, Daniel, De La Fouchardiere, Christelle, Desseigne, Françoise, Wang, Qing, Attignon, Valery, Fondrevelle, Marie-Eve, De La Fouchardiere, Arnaud, Perol, Maurice, Cassier, Philippe, Seigne, Christelle, Perol, David, Coquard, Isabelle Ray, Meeus, Pierre, Fayette, Jerome, Flechon, Aude, Le Cesne, Axel, Penel, Nicolas, Tredan, Olivier, Blay, Jean-Yves
Publicado no Oncotarget (2015)